Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Nasdaq 100: Amazon Earnings Today – Will It Finally Surpass Walmart in Revenue?
11:00am, Thursday, 06'th Feb 2025
Amazon reports earnings today—will it surpass Walmart in revenue? Key insights on cloud growth, AI spending, and retail sales impact on US stocks.
S&P 500 Forecast: Broad Market Edges Higher, But Qualcomm and Arm Weigh on Nasdaq 100
09:30am, Thursday, 06'th Feb 2025
S&P 500 edges higher as earnings take focus, but Qualcomm and Arm drag Nasdaq 100 lower. Traders eye job data and Fed policy for market direction.
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Thursday, 06'th Feb 2025
PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of pati
Nasdaq Grants Santech Holdings Limited Extension to File its Annual Report on Form 20-F
05:00am, Thursday, 06'th Feb 2025
HONG KONG, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Santech Holdings Limited (NASDAQ: STEC) (“Santech” or the “Company”) announced today that The Nasdaq Stock Market LLC (“Nasdaq”) has determined
CERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
08:00pm, Wednesday, 05'th Feb 2025
SOUTH SAN FRANSCISCO, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advanc
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:05pm, Wednesday, 05'th Feb 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2025, the Compensation Committee of Puma's Board of Directors approved
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 05'th Feb 2025
WESTLAKE VILLAGE, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in January 2025
01:58pm, Wednesday, 05'th Feb 2025
January 2025 was a bullish month for many Nasdaq-listed names. But that wasn't the case for all of them.
Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap
10:15am, Wednesday, 05'th Feb 2025
WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia'
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
09:29am, Wednesday, 05'th Feb 2025
GARDEN CITY, N.Y., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on
Nuvini Regains Compliance with Nasdaq Listing Rule 5250(c)(2)
09:25am, Wednesday, 05'th Feb 2025
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, today announced
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
09:22am, Wednesday, 05'th Feb 2025
60 Degrees Pharma (SXTP) announces a $1.075M registered direct offering, issuing stock and warrants to fund working capital and corporate initiatives.
Nasdaq 100 and S&P 500: Futures Drop as Alphabet, AMD, and Apple Weigh on Markets
08:00am, Wednesday, 05'th Feb 2025
Nasdaq 100 drops as Alphabet and AMD tumble after earnings. Apple faces China scrutiny, adding pressure to US stocks.
Nasdaq 100 Slides as China's Apple Probe and Google's Earnings Miss Shake Market Sentiment
05:20am, Wednesday, 05'th Feb 2025
Apple drops 3% as China weighs App Store probe, while Google sinks 9% on weak earnings. Nvidia edges higher, but risks loom.
Virtune AB (Publ) launches two new Crypto ETPs on Nasdaq Helsinki
04:24am, Wednesday, 05'th Feb 2025
Helsinki, February 5th, 2025 - Virtune, a Swedish regulated digital asset manager and issuer of crypto exchange-traded products, today announced the listing of Virtune Avalanche ETP and Virtune Staked
